Explore more publications!

Solomon Islands Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Solomon Islands Health Reporter.

Press releases published on November 24, 2025

Providence Saint John’s Earns Magnet Recognition, The Gold Standard in Nursing Excellence
Curaechoice Selects CVS Caremark at its PBM
Validation study for EchoSolv HF completed at the Mayo Clinic – Study delivers exceptional results
Korean distributor agreement with DK Healthcare in South Korea
Outlook Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference
YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics
Capricor Therapeutics Presents New Data Demonstrating a Scalable Framework for Loading Therapeutic Oligonucleotides into Exosomes at AAEV 2025
JenaValve Announces New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
FibroBiologics Announces $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference
OneMedNet to Showcase Transformative New Platform at RSNA 2025
Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review
Biodexa Activates First European Site for Registrational Phase 3 Serenta Trial in FAP
Pharmaceutical Packaging Market worth $364.11 billion by 2030 at 15.8%, says MarketsandMarkets™
CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative Breast Cancer at the San Antonio Breast Cancer Symposium
Biotech Valuations Rise as New Clinical Platforms Show Progress
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions